GlassScriptPhysician profile
Jung Park
NPI 1487843587
$1,668.63
in general payments reported to CMS, 2019-2025
16 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $316 · 2021: $382 · 2022: $94.71 · 2023: $329 · 2024: $227 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $730.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $396.95 | 2021-2025 | Total30, Dailies Total1, Precision7 |
| Coopervision INC. | $340.90 | 2023-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Sun Pharmaceutical Industries INC. | $221.42 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $157.48 | 2019-2020 | |
| Eyevance Pharmaceuticals LLC | $134.83 | 2021 | |
| Bausch & Lomb Americas INC. | $95.58 | 2022-2024 | Infuse, Biotrue One Day |
| Glaukos Corporation | $75.85 | 2019 | |
| Oyster Point Pharma, INC. | $63.88 | 2022-2023 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $40.91 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $29.21 | 2024 | Xdemvy |
| Biotissue Holdings INC. | $22.50 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.36 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $19.88 | 2025 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Allergan, INC. | $16.04 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jung Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.